Abstract:Non-nucleic acid targets, consisting primarily of metal ions, organic small molecules and proteins. They act as important biomolecules or cell surface markers, supplying integrated and comprehensive bio-diagnostic information for the early diagnosis and treatment of diseases. Meanwhile, the analysis of non-nucleic acid targets also offers the foundation for individualized medicine and precision therapy. Therefore, a versatile platform for non-nucleic acid targets requires development. Clustered regularly interspaced short palindromic repeats-associated protein (CRISPR/Cas) systems is driving a revolution in medical diagnostics due to high base-resolution and isothermal signal amplification. Nevertheless, the majority of CRISPR/Cas settings reported currently are targeted for nucleic acids, leaving restricted usage to non-nucleic acid targets. This is owing to the lack of suitable signal recognition transduction elements for connecting CRISPR to non-nucleic acid targets. Functional nucleic acids (FNAs), comprising aptamers and nucleic acid enzymes, are of great concern to the biological and medical professions because of their specific target recognition and catalytic properties. As appropriate, functional recognition elements, FNAs can be integrated into CRISPR/Cas systems to exploit the powerful capabilities of both. This review emphasizes the technical tricks of integrating CRISPR/Cas systems and FNAs for non-nucleic acid targeting diagnostic applications. We first offer a general overview and the current state of research in diagnostics for CRISPR/Cas and FNAs, respectively, highlighting strengths and shortcomings. A categorical summary of non-nucleic acid-targeted diagnostics is provided, with a key emphasis on fundamental insights into the versatile non-nucleic acid-targeted diagnostic toolbox. We then review emerging diagnostic strategies based on CRISPR/Cas systems and FNAs that are fast, accurate and efficient in detecting non-nucleic acid targets. Finally, we identify the challenges that remain in this emerging field and look to the future of the field, expanding to the integration of nanomaterials, development of wearable devices and point-of-care testing.

Challenges and perspectives of CRISPR-based technology for diagnostic applications

Advances and Challenges of Signal Readout Systems in CRISPR-based Biosensors for Point-of-care Testing of Nucleic Acid

CRISPR-Cas Biochemistry and CRISPR-Based Molecular Diagnostics.

CRISPR/cas systems redefine nucleic acid detection: Principles and methods

Point‐of‐Care Pathogen Detection with CRISPR‐based Programmable Nucleic Acid Binding Proteins

CRISPR-Cas assisted diagnostics: A broad application biosensing approach

Critical review on where CRISPR meets molecular diagnostics

Advancements in CRISPR-Based Biosensing for Next-Gen Point of Care Diagnostic Application

Point-of-care CRISPR/Cas nucleic acid detection: Recent advances, challenges and opportunities

CRISPR/Cas-based nucleic acid detection strategies: Trends and challenges

Integration of CRISPR/Cas with functional nucleic acids as versatile toolbox for non-nucleic acid target diagnostics: a review

Research progress of CRISPR-based biosensors and bioassays for molecular diagnosis

CRISPR Cas system: A strategic approach in detection of nucleic acids

CRISPR Assays for Disease Diagnosis: Progress to and Barriers Remaining for Clinical Applications

Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6

Next-generation CRISPR-based Diagnostic Tools for Human Diseases

CRISPR-based diagnostics of different biomolecules from nucleic acids, proteins, and small molecules to exosomes

CRISPR: The Frontier Technology of Next-Generation RNA Detection

Advances in Amplification-Free Detection of Nucleic Acid: CRISPR/Cas System As a Powerful Tool.

CRISPR-based electrochemical biosensors: an alternative for point-of-care diagnostics?

Biosensing platforms for DNA diagnostics based on CRISPR/Cas nucleases: towards the detection of nucleic acids at the level of single molecules in non-laboratory settings